156 results
Page 4 of 8
424B3
EX-99.2
9oinqpsr2ey
25 Feb 22
Prospectus supplement
8:39am
424B3
EX-99.1
qq6vpr9
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.1
hayeiokppcd6yh01dy
25 Feb 22
Regulation FD Disclosure
8:38am
8-K
EX-99.2
h6g 2i61j
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
EX-99.1
bcaj4y
1 Dec 21
Prospectus supplement
8:25am
424B3
EX-99
cl5a4hz8
1 Dec 21
Prospectus supplement
8:25am
8-K
9ol4qu4a1af90g3tky6c
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
EX-99.1
1gvbz2m62wqge19p4
1 Dec 21
Departure of Directors or Certain Officers
8:14am
8-K
EX-99.1
ut8e9e3a
19 Nov 21
Regulation FD Disclosure
8:09am
424B3
g4yd6m7w lic4
12 Nov 21
Prospectus supplement
8:41am
424B3
vqyrc0m4wcro
28 Sep 21
Prospectus supplement
9:07am
8-K
ze2qmg5
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
8-K
EX-99.1
rm530d vyg
28 Sep 21
Entry into a Material Definitive Agreement
8:53am
424B3
c8vliqvshgtp05
13 Aug 21
Prospectus supplement
5:25pm
8-K
EX-99.1
rvfjysj1qj5 n22
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
bgmzs9gzw
5 Aug 21
Prospectus supplement
4:26pm
8-K
tl2yosc
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am